Experimental Group:XiangShaLiuJunZi decotion

2 trials

Sponsors

Fudan University Shanghai Cancer Center

Conditions

Hepatocellular Carcinoma

Early Phase 1

A Prospective, Randomized, Double-Blind Study of Xiangsha Liujunzi Decotion Compared With Placebo in the First-Line Treatment of Unresectable Hepatocellular Carcinoma

RecruitingChiCTR2000039401

Fudan University Shanghai Cancer CenterHepatocellular Carcinoma

Start: 2021-01-01Updated: 2021-02-01

A Prospective, Randomized, Double-Blind Study of Xiangsha Liujunzi Decotion Compared With Placebo in the First-Line Treatment of Unresectable Hepatocellular Carcinoma

RecruitingITMCTR2100004340

Fudan University Shanghai Cancer CenterHepatocellular Carcinoma

Start: 2021-01-01Updated: 2023-02-20